CVE-2023-26913

CVE-2023-26913 is a medium-severity vulnerability in Evolucare Ecs Imaging with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.

Frequently asked questions

What is CVE-2023-26913?
EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.
How severe is CVE-2023-26913?
CVE-2023-26913 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2023-26913 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (39th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-26913?
CVE-2023-26913 affects Evolucare Ecs Imaging. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-26913?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-26913 published?
CVE-2023-26913 was published on 2023-03-22 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Evolucare Ecs Imaging

All CVEs affecting Evolucare Ecs Imaging →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →